Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis

NCT02871479 is registered in ClinicalTrials.gov with Santalis Pharmaceuticals, Inc. as lead sponsor.

NCT NCT02871479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02871479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis
Lead sponsor
Santalis Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
April 21, 2017
Completion date
August 31, 2018
Enrollment
71 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, eczema